Liver Fat Quantification Tools Released for Philips EPIQ Elite and Affiniti Ultrasound Systems

By News Release

Royal Philips received US FDA 510(k) clearance for its new Liver Fat Quantification tools as part of the latest release of its ultrasound systems EPIQ Elite and Affiniti, bringing the cost and accessibility advantages of sonography to the diagnosis of early-stage liver disease. The company will highlight the new release at the annual meeting of the Radiological Society of North America (RSNA), November 28-December 2.

"With a quantitative way of measuring liver fat, it is a lot easier for us to let the referring physician know where the patient is quantitatively on the NAFLD spectrum,” said Richard G. Barr, MD, PhD, President, Radiology Consultant, Inc., Youngstown, Ohio, and Medical Director at Southwoods Imaging. “With traditional gray scale imaging, we could only tell if the liver had a high degree of fatty infiltration or if it was normal, but it was very hard to assess whether fatty liver disease was mild, moderate or severe. Attenuation imaging now gives us a numerical value that will enable us to follow the patient over time. With the combination of quantitative fat assessment and liver stiffness the probability of NASH can be assessed.”

Philips Ultrasound Systems EPIQ and Affiniti on Release 9.0 now support radiologists and hepatologists in the diagnosis and treatment from early-stage to advanced liver disease, making it easier to perform longitudinal studies to assess liver disease progression. With this latest release, the company further strengthens its liver solution and expands its full availability to the Affiniti 70 and Affiniti 50 – supported by the innovative PureWave C5-1 Curved transducer, now also available on Affiniti 50 – to enhance diagnostic confidence in abdominal, hepatology, and vascular and gynaecological ultrasound exams as well. The new Liver Fat Quantification tools complement the company’s existing ultimate solution for liver assessment with real-time shear wave imaging, contrast enhanced ultrasound (CEUS) and fusion and navigation. The Liver Fat Quantification tools, which feature ease of use plus intuitive workflow and reporting, is available on both the C5-1 and the small footprint mC7-2 MicroConvex transducer, to accommodate different body types, from smaller patients to high BMI patients.

With the extended remote functionality of Collaboration Live on both the EPIQ and Affiniti platforms, technicians can also securely access on-demand, real-time guidance and decision support to enhance diagnostic confidence and workflow efficiency during exams.

“Today’s announcement demonstrates the continued advancement of our ultrasound portfolio to increase diagnostic confidence and workflow efficiency,” said Jeff Cohen, General Manager of Ultrasound at Philips. “Accessible ultrasound-based Liver Fat Quantification is a screening and early diagnostic tool that will allow many more patients to take their health into their own hands by making simple lifestyle changes.”

Back To Top

Liver Fat Quantification Tools Released for Philips EPIQ Elite and Affiniti Ultrasound Systems .  Appl Radiol. 

By News Release| November 16, 2021

About the Author

News Release

News Release



Copyright © Anderson Publishing 2022